by [150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global stem cell therapy market was valued at around USD 9.87 billion in 2021 and is expected to register revenues worth USD 31.41 billion by the end of 2030, growing at an exceptional CAGR of approximately 13.73% between 2022 and 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1989
Stem Cell Therapy Market Report Scope
A recent study by Precedence Research on the stem cell therapy market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the stem cell therapy market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of stem cell therapy. The study also provides the dynamics that are responsible for influencing the future status of the stem cell therapy market over the forecast period.
A detailed assessment of the stem cell therapy market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the stem cell therapy market along with their product portfolio enhances the reliability of this comprehensive research study.
Competition Landscape
The report has engulfed a chapter on the global stem cell therapy market’s competitive landscape, which provides detailed analysis and insights on companies offering stem cell therapy. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.
This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.
Read Also@ Starch Derivatives Market Size to Worth Around US$ 79.4 Billion by 2030
Some of the Prominent Players in the Stem Cell Therapy Market Include:
- Caladrius
- CELGENE CORPORATION
- ReNeuron Group plc
- Virgin Health Bank
- Opexa Therapeutics, Inc.
- Pluristem Therapeutics Inc
- STEMCELL Technologies Inc.
- Biovault family
- Precious Cells International Ltd
- Mesoblast Ltd
- Seneca Biopharmaceuticals, Inc.
Stem Cell Therapy Market Segmentation
By Product
- Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Others
- Human Embryonic Stem Cells (HESCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Very Small Embryonic Like Stem Cells
By Therapy Type
- Autologous
- Allergenic
By Application
- Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
- Drug Discovery and Development
By Technology
- Cell Acquiition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
- Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
- Cryopreservation
- Expansion and Sub-Culture
By End User
- Hospitals
- Research institutes
- surgical institutes
- Orders
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global stem cell therapy market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the stem cell therapy market.
The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.
Why should you invest in this report?
If you are aiming to enter the global stem cell therapy market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for stem cell therapy are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Stem Cell Therapy Market
5.1. COVID-19 Landscape: Stem Cell Therapy Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Stem Cell Therapy Market, By Product
8.1. Stem Cell Therapy Market, by Product, 2022-2030
8.1.1. Adult Stem Cells (ASCs)
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Human Embryonic Stem Cells (HESCs)
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Induced Pluripotent Stem Cells (iPSCs)
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Very Small Embryonic Like Stem Cells
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Stem Cell Therapy Market, By Therapy Type
9.1. Stem Cell Therapy Market, by Therapy Type, 2022-2030
9.1.1. Autologous
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Allergenic
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Stem Cell Therapy Market, By Application
10.1. Stem Cell Therapy Market, by Application, 2022-2030
10.1.1. Regenerative Medicine
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Stem Cell Therapy Market, By Technology
11.1. Stem Cell Therapy Market, by Technology, 2022-2030
11.1.1. Cell Acquiition
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cell Production
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Cryopreservation
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Expansion and Sub-Culture
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Stem Cell Therapy Market, By End User
12.1. Stem Cell Therapy Market, by End User, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Research institutes
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. surgical institutes
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Orders
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Stem Cell Therapy Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.7. Germany
13.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.8. France
13.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Rest of Europe
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.犀利士
6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.7. China
13.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. Japan
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.9. Rest of APAC
13.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.7. North Africa
13.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. South Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.9. Rest of MEA
13.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.7. Rest of LATAM
13.5.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.7.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. Caladrius
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. CELGENE CORPORATION
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. ReNeuron Group plc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Virgin Health Bank
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Opexa Therapeutics, Inc
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pluristem Therapeutics Inc
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. STEMCELL Technologies Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Biovault family
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Precious Cells International Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Mesoblast Ltd
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1989
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
